Trial intelligence / Profile preview

BERTA: Bemiparin vs UFH Bridging Therapy

NCT00484822Phase 3Terminated

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Feb 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bemiparin in thromboembolism, sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Started Feb 2007; status: terminated.

02

Drugs

bemiparin
03

Conditions

thromboembolism

Beyond the preview

Go deeper on NCT00484822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00484822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call